| Code | Name | Description |
|---|---|---|
| DM | Demographics | Subject demographics and characteristics |
| SE | Subject Elements | Planned protocol elements for each subject |
| SV | Subject Visits | Subject visit dates and related information |
| CO | Comments | Comments and narrative information |
| AE | Adverse Events | Adverse events reported during the study |
| MH | Medical History | Subject-relevant medical history |
| DS | Disposition | Subject disposition information including completion/discontinuation |
| HO | Hospitalization | Data related to hospitalization during the study |
| DD | Death Details | Details related to subject deaths |
| CM | Concomitant Medications | Medications taken during the study period |
| EX | Exposure | Exposure to protocol-specified study treatment |
| PR | Procedures | Procedures performed during the study |
| DA | Drug Accountability | Accountability of study drug dispensation and return |
| VS | Vital Signs | Vital signs measurements taken during the study |
| LB | Laboratory Tests | Laboratory test results |
| EG | Electrocardiogram | Electrocardiogram test results |
| PE | Physical Exam | Physical examination findings |
| QS | Questionnaire | Questionnaire and patient-reported outcomes |
| FA | Findings About | Findings about other domains |
| MB | Microbiology Specimen | Microbiological specimen data |
| TU | Tumor Identification | Identification of target/non-target tumors and lesions |
| TR | Tumor Response | Tumor response evaluations |
| SS | Subject Status | Status and condition information about the subject |
| IE | Inclusion/Exclusion Criteria Not Met | Details about inclusion/exclusion criteria not met |
| PK | Pharmacokinetics | Pharmacokinetic analysis results |
| PD | Pharmacodynamics | Pharmacodynamic measurements and analysis |